Page 5 - Dexcom Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MELBOURNE, Australia and SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Global MedTech start-up Nutromics has raised an additional US $14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics' continued expansion across Australia and the United States. Strategic investors included Dexcom Ventures, VU Venture Partners, and Artesian Investments. This funding demonstrates a resounding level of investor confidence in the potential of Nutromics' technology, which will tackle some of healthcare's most challenging conditions through the power of continuou...

The fund will be zeroing in on sensing tech, data analytics, remote patient monitoring and population health.

MedCity News Dexcom launches first VC fund Dexcom launched its first venture fund. The company, which makes continuous glucose monitors, plans to invest in glucose sensing technologies and metabolic monitoring. Shares1   Medical device company Dexcom is launching its first venture fund. The San Diego-based company, one of a few competing for dominance in the market for continuous glucose monitors, plans to invest in technologies related to its core business and adjacent technologies. Steve Pacelli, Dexcom’s executive vice president of strategy and corporate development, will lead Dexcom...

The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.